JMUB | NIM | JMUB / NIM | |
Gain YTD | 0.549 | 7.666 | 7% |
Net Assets | 3.32B | 122M | 2,719% |
Total Expense Ratio | 0.18 | 0.57 | 32% |
Turnover | 39.00 | 20.00 | 195% |
Yield | 3.53 | 3.37 | 105% |
Fund Existence | 7 years | 33 years | - |
JMUB | NIM | |
---|---|---|
RSI ODDS (%) | 3 days ago45% | 3 days ago68% |
Stochastic ODDS (%) | 3 days ago33% | 3 days ago62% |
Momentum ODDS (%) | 3 days ago29% | 3 days ago86% |
MACD ODDS (%) | 3 days ago44% | 3 days ago78% |
TrendWeek ODDS (%) | 3 days ago36% | 3 days ago81% |
TrendMonth ODDS (%) | 3 days ago34% | 3 days ago84% |
Advances ODDS (%) | 5 days ago38% | 4 days ago81% |
Declines ODDS (%) | 3 days ago49% | 19 days ago69% |
BollingerBands ODDS (%) | 3 days ago34% | 3 days ago63% |
Aroon ODDS (%) | 3 days ago25% | 7 days ago80% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SHPCX | 12.71 | 0.09 | +0.71% |
Saratoga Health & Biotechnology C | |||
FCUPX | 20.43 | 0.04 | +0.20% |
NYLI PineStone U.S. Equity Class P | |||
ASDEX | 139.21 | -0.45 | -0.32% |
American Century Select R6 | |||
MUERX | 36.03 | -0.13 | -0.36% |
MFS Blended Research Core Equity R1 | |||
FMEFX | 42.59 | -0.16 | -0.37% |
Nuveen Small/Mid Cap Growth Opp R6 |
A.I.dvisor tells us that JMUB and PLUS have been poorly correlated (+1% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that JMUB and PLUS's prices will move in lockstep.
Ticker / NAME | Correlation To JMUB | 1D Price Change % | ||
---|---|---|---|---|
JMUB | 100% | -0.02% | ||
PLUS - JMUB | 1% Poorly correlated | -0.77% | ||
RTX - JMUB | 0% Poorly correlated | -0.20% |